Larvol Delta - Allegro-Ophthalmics-Receives-FDA-Agreement-Under-Special-Protocol-Assessment-SPA-for-Phase-2b3-Clinical-Trial-of-Risuteganib-for-the-Treatment-of-Intermediate-Dry-AMD

Luminate (risuteganib) - Allegro Ophthalmics

https://www.prnewswire.com/news-releases/allegro-ophthalmics-receives-fda-agreement-under-special-protocol-assessment-spa-for-phase-2b3-clinical-trial-of-risuteganib-for-the-treatment-of-intermediate-dry-amd-301795701.html

Apr 12, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next